MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
48.89
+1.03 (2.15%)
At close: Jul 3, 2025, 1:00 PM
46.72
-2.17 (-4.44%)
After-hours: Jul 3, 2025, 3:22 PM EDT
MLTX Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$73.33
Upside
+49.99%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $67 | Buy | Reiterates | $67 | +37.04% | Jun 3, 2025 |
| Wolfe Research | Wolfe Research | Hold → Buy Upgrades $61 | Hold → Buy | Upgrades | $61 | +24.77% | May 19, 2025 |
| Needham | Needham | Strong Buy Reiterates $66 | Strong Buy | Reiterates | $66 | +35.00% | May 13, 2025 |
| Needham | Needham | Strong Buy Reiterates $66 | Strong Buy | Reiterates | $66 | +35.00% | Apr 30, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $67 | Buy | Initiates | $67 | +37.04% | Mar 18, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $82 → $73 | Strong Buy | Maintains | $82 → $73 | +49.31% | Feb 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +104.54% | Feb 27, 2025 |
| Needham | Needham | Strong Buy Maintains $62 → $66 | Strong Buy | Maintains | $62 → $66 | +35.00% | Feb 27, 2025 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $62 → $82 | Hold → Strong Buy | Upgrades | $62 → $82 | +67.72% | Jan 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +104.54% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +104.54% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +104.54% | Nov 8, 2024 |
| Wedbush | Wedbush | Buy Initiates $92 → $73 | Buy | Initiates | $92 → $73 | +49.31% | Nov 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +104.54% | Oct 15, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +104.54% | Sep 12, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.